Crohn's Disease

Scientific session (expert guidance) - Giuseppe Sica (Italy) at ESCP Dublin 2022

Educational session - Gabriele Bislenghi (Belgium), Andreas Renders (Belgium) at ESCP Dublin 2022

Breakfast session - Quentin Denost (France), Roel Hompes (Belgium), Conor Delaney (USA), Ellen van Eetvelde (Belgium) at ESCP Dublin 2022

ESCP/ECCO Symposium - Christiane Buskens (The Netherlands) at ESCP Dublin 2022

ESCP/ECCO Symposium - Michel Adamina (Switzerland) at ESCP Barcelona 2021

Takeda Satellite Symposium - Michel Adamina at ESCP Barcelona 2021

New trials forum - Steve Brown (UK) at ESCP Barcelona 2021

Symposium - Christianne Buskens (The Netherlands) at ESCP Virtually Vilnius 2020

Symposium - Antonino Spinelli (Italy) at ESCP Virtually Vilnius 2020

Educational session - Janindra Warusavitarne (UK) at ESCP Virtually Vilnius 2020

Symposium - Yves Panis (France) at ESCP Vienna 2019

ESCP/ECCO Symposium - Amy Lightner (USA) at ESCP Vienna 2019

ESCP/ECCO Symposium - Willem Bemelman (The Netherlands) at ESCP Vienna 2019

Educational session - Jasper Stijns (The Netherlands) at ESCP Vienna 2019

Educational session - Baljit Singh (UK) at ESCP Vienna 2019

Educational session - Samson Tou (UK) at ESCP Vienna 2019

Strictureplasty vs Resection debate - Janindra Warusavitarne (UK) and Andre D'hoore (Belgium) with Willem Bemelman (The Netherlands) and Omar Faiz (UK) at ESCP Nice 2018

Strictureplasty vs Resection debate - Janindra Warusavitarne (UK) at ESCP Nice 2018

Strictureplasty vs Resection debate - Andre D'hoore (Belgium) at ESCP Nice 2018

Trainee Video Session - Willem Bemelman (The Netherlands) at ESCP Nice 2018

ESCP/ECCO Symposium - Andre D'Hoore (Belgium) at ESCP Nice 2018

International Trials Results Forum - Willem Bemelman (The Netherlands) with expert commentary by Eloy Espin Basany (Spain) at ESCP Berlin 2017

Educational session - Willem Bemelman (The Netherlands) and Krisztina Gecse (The Netherlands) at ESCP Berlin 2017

The exact etiology of Crohn’s disease remains unclear, but current evidence suggests that the intestinal mucosal barrier is compromised, allowing invasion of intestinal bacteria into the bowel. Conservative measures are the mainstay of treatment. Surgery is primarily used to treat complications of Crohn’s disease and to improve quality of life. Certain situations such as enterovesical fistulas are absolute indications for surgery. In isolated ileocecal Crohn’s disease, primary ileocecal resection is a therapeutic alternative equivalent to the escalation of medical treatment. Adequate preoperative preparation, including improving nutritional status, weaning off or stopping immunosuppressive medication, and preoperatively draining abscesses, can decrease complication rates of surgery for Crohn’s disease. Unless neoplasia is present, bowel-sparing techniques (strictureplasty, limited resections) should be used. The laparoscopic approach is possible for most indications; its superiority over the open approach has been shown for primary ileocecal resection. Seton drainage is a good option to retain quality of life for patients with complex perianal fistulas.

Keynote Lecture - Andre D'Hoore at ESCP Milan 2016

Educational session - Willem Bemelman at ESCP Milan 2016

Symposium (in collaboration with s-ECCO) - Gert Van Assche at ESCP Dublin 2015

Symposium (in collaboration with s-ECCO) - Omar Faiz at ESCP Dublin 2015

Free Paper (IBD) - Nuha Yassin at ESCP Dublin 2015

Oral Poster (IBD) - Adeline Germain at ESCP Dublin 2015